Cargando…

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study

SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Qerem, Walid, Al Bawab, Abdel Qader, Hammad, Alaa, Ling, Jonathan, Alasmari, Fawaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950968/
https://www.ncbi.nlm.nih.gov/pubmed/35335042
http://dx.doi.org/10.3390/vaccines10030410
_version_ 1784675270512345088
author Al-Qerem, Walid
Al Bawab, Abdel Qader
Hammad, Alaa
Ling, Jonathan
Alasmari, Fawaz
author_facet Al-Qerem, Walid
Al Bawab, Abdel Qader
Hammad, Alaa
Ling, Jonathan
Alasmari, Fawaz
author_sort Al-Qerem, Walid
collection PubMed
description SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire for Jordanian adults (n = 915) to determine how individuals who have finished the current vaccination regimen feel about a prospective COVID-19 booster shot and what factors might influence their decision. Almost half of the participants (44.6%) intended to get the booster dose of the COVID-19 vaccine. The most frequently mentioned reasons for participants’ reluctance to get the COVID-19 vaccine booster dose were “The benefits of booster dose have not been scientifically proven” (39.8%), followed by “I took the last dose a short time ago, and there will be no need to take the booster dose for at least a year” (24.6%). In turn, “I was infected with COVID-19; thus, I do not require the booster dose” was the least reported reason (13.1%). These findings highlight the considerable hesitancy toward COVID-19 booster immunization among Jordanians, as well as the variables associated with vaccine hesitancy and the most frequently mentioned reasons for hesitancy, which will aid in creating excellent campaigns regarding booster doses.
format Online
Article
Text
id pubmed-8950968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89509682022-03-26 Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study Al-Qerem, Walid Al Bawab, Abdel Qader Hammad, Alaa Ling, Jonathan Alasmari, Fawaz Vaccines (Basel) Article SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire for Jordanian adults (n = 915) to determine how individuals who have finished the current vaccination regimen feel about a prospective COVID-19 booster shot and what factors might influence their decision. Almost half of the participants (44.6%) intended to get the booster dose of the COVID-19 vaccine. The most frequently mentioned reasons for participants’ reluctance to get the COVID-19 vaccine booster dose were “The benefits of booster dose have not been scientifically proven” (39.8%), followed by “I took the last dose a short time ago, and there will be no need to take the booster dose for at least a year” (24.6%). In turn, “I was infected with COVID-19; thus, I do not require the booster dose” was the least reported reason (13.1%). These findings highlight the considerable hesitancy toward COVID-19 booster immunization among Jordanians, as well as the variables associated with vaccine hesitancy and the most frequently mentioned reasons for hesitancy, which will aid in creating excellent campaigns regarding booster doses. MDPI 2022-03-09 /pmc/articles/PMC8950968/ /pubmed/35335042 http://dx.doi.org/10.3390/vaccines10030410 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Al-Qerem, Walid
Al Bawab, Abdel Qader
Hammad, Alaa
Ling, Jonathan
Alasmari, Fawaz
Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title_full Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title_fullStr Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title_full_unstemmed Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title_short Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
title_sort willingness of the jordanian population to receive a covid-19 booster dose: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950968/
https://www.ncbi.nlm.nih.gov/pubmed/35335042
http://dx.doi.org/10.3390/vaccines10030410
work_keys_str_mv AT alqeremwalid willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy
AT albawababdelqader willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy
AT hammadalaa willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy
AT lingjonathan willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy
AT alasmarifawaz willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy